Candel Therapeutics, Inc.CADLNASDAQ

Revenue (LTM)

Net Income (LTM)

$-38M

+30.8% YoY

Free Cash Flow

$-39M

Revenue CAGR (5Y)

—

Marginsimproving

FCF($0.0B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	0	0↓0.0%	0	0	0
Gross Profit	-14	0↑100.9%	-24↓19284.0%	-1↑95.9%	-1↑14.6%
Operating Income	-26	-35↓35.0%	-38↓10.6%	-33↑13.1%	-48↓44.6%
Net Income	-36	-19↑48.0%	-38↓101.9%	-55↓45.4%	-38↑30.8%
EBITDA	-25	-16↑36.0%	-37↓129.5%	-52↓39.2%	-47↑9.0%
EPS Diluted	-1.26	-0.10↑92.1%	-1.31↓1217.9%	-1.74↓32.8%	-0.72↑58.6%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	83	70↓15.2%	35↓49.5%	103↑189.9%	120↑16.6%
Total Current Assets	85	72↓15.3%	37↓48.9%	104↑182.1%	120↑15.3%
Total Assets	89	79↓12.0%	41↓47.5%	107↑159.4%	125↑17.2%
Total Current Liabilities	5	6↑4.7%	14↑152.6%	38↑164.6%	9↓76.0%
Total Liabilities	25	31↑22.9%	28↓7.6%	41↑42.5%	73↑80.7%
Total Equity	64	48↓25.6%	13↓73.3%	66↑420.4%	52↓21.7%
Total Debt	1	23↑3971.4%	23↓0.2%	13↓40.8%	2↓85.9%
Net Debt	-82	-47↑42.4%	-13↑73.2%	-89↓604.9%	-118↓32.1%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-22	-31↓41.4%	-34↓9.0%	-27↑21.1%	-38↓41.8%
Capital Expenditure	-2	-1↑29.3%	-0↑64.8%	-0↑96.5%	-1↓3568.8%
Free Cash Flow	-24	-33↓36.0%	-35↓6.1%	-27↑22.1%	-39↓43.9%
Stock-Based Comp	3	2↓22.1%	3↑34.0%	5↑71.9%	4↓28.1%
Net Change in Cash	48	-13↓126.7%	-35↓171.9%	67↑294.1%	17↓74.4%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance